Elevated levels of TMAO further promote cardiac hypertrophy and fibrosis through the transforming growth factor-β-mothers against decapentaplegic homolog 2/3 (TGF-β-Smad2/3) signaling pathway, thereby inducing heart failure (53). This evidence concerns the gene SMAD2 and cardiac hypertrophy.